Small Business Innovation Research · Small Business Technology Transfer
Angion Biomedica Corp.: SBIR & STTR awards
1 awards worth $149.8K to 1 companies since 2014 match these filters. Phase I tests an idea (usually a few hundred thousand dollars); Phase II builds it (often $1M or more).
Angion Biomedica Corp.'s federal contracts and grants · All SBIR & STTR awards
Awards by year
| Year | Phase I | Phase II | Amount |
|---|---|---|---|
| 2014 | 1 | 0 | $149.8K |
The latest year fills in over months: agencies report awards to SBIR.gov with a lag.
Latest matching awards
| Award | Company | Agency | Phase | Amount | Date |
|---|---|---|---|---|---|
| SBIR Phase I: A Novel Extended Delivery Dual-action Platform for Peptide-based Anti-fibrotics · topic BC | Angion Biomedica Corp. · California | National Science Foundation | SBIR Phase I | $149.8K | 2014-01-01 |
Source: SBIR.gov award data (SBA) ↗, awards through 2026-08-28. Amounts are as agencies report them to SBA. SBIR/STTR contracts also appear in USAspending as ordinary awards; grants (NIH, NSF, DOE) appear as assistance. Open topics are posted by each agency; see Opportunities for contract notices.